Gangliosides in cerebrospinal fluid in children with autism spectrum disorders. 1998

V Nordin, and A Lekman, and M Johansson, and P Fredman, and C Gillberg
Department of Child and Adolescent Psychiatry, Annedals Clinics, Göteborg, Sweden.

Gangliosides are sialic acid-containing glycolipids found in all cells, especially abundant in nerve cells and mainly situated on outer-membrane surfaces. The aim of this study was to provide data on the concentration of gangliosides in the CSF of children and adolescents with autism spectrum disorders (ASD) - 66 with autistic disorder, and 19 with other autism spectrum disorders. The comparison group consisted of 29 children and adolescents, whose CSF had been sampled to exclude acute infectious CNS disorder. The concentrations of the gangliosides GM1, GD1a, GD1b, and GT1b were determined using a microimmunoaffinity technique. The ASD group had a significantly higher concentration of ganglioside GM1 compared with the comparison group. The GM1 increase could not be explained as secondary to other clinical factors. Mean ganglioside levels did not differentiate subgroups with autistic disorder and those with a more atypical clinical picture, nor subgroups with known medical disorders and those with idiopathic autism. Altered patterns of gangliosides in the CNS might reflect important correlates of pathogenesis in autism.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D009460 Neurologic Examination Assessment of sensory and motor responses and reflexes that is used to determine impairment of the nervous system. Examination, Neurologic,Neurological Examination,Examination, Neurological,Examinations, Neurologic,Examinations, Neurological,Neurologic Examinations,Neurological Examinations
D009483 Neuropsychological Tests Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. Aphasia Tests,Cognitive Test,Cognitive Testing,Cognitive Tests,Memory for Designs Test,Neuropsychological Testing,AX-CPT,Behavioral Assessment of Dysexecutive Syndrome,CANTAB,Cambridge Neuropsychological Test Automated Battery,Clock Test,Cognitive Function Scanner,Continuous Performance Task,Controlled Oral Word Association Test,Delis-Kaplan Executive Function System,Developmental Neuropsychological Assessment,Hooper Visual Organization Test,NEPSY,Neuropsychologic Tests,Neuropsychological Test,Paced Auditory Serial Addition Test,Repeatable Battery for the Assessment of Neuropsychological Status,Rey-Osterrieth Complex Figure,Symbol Digit Modalities Test,Test of Everyday Attention,Test, Neuropsychological,Tests, Neuropsychological,Tower of London Test,Neuropsychologic Test,Test, Cognitive,Testing, Cognitive,Testing, Neuropsychological,Tests, Cognitive
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D005677 G(M1) Ganglioside A specific monosialoganglioside that accumulates abnormally within the nervous system due to a deficiency of GM1-b-galactosidase, resulting in GM1 gangliosidosis. GM1 Ganglioside,Monosialosyl Tetraglycosyl Ceramide,GM1a Monosialoganglioside,Ceramide, Monosialosyl Tetraglycosyl,Ganglioside, GM1,Monosialoganglioside, GM1a,Tetraglycosyl Ceramide, Monosialosyl

Related Publications

V Nordin, and A Lekman, and M Johansson, and P Fredman, and C Gillberg
October 2012, Journal of autism and developmental disorders,
V Nordin, and A Lekman, and M Johansson, and P Fredman, and C Gillberg
June 2016, Journal of child neurology,
V Nordin, and A Lekman, and M Johansson, and P Fredman, and C Gillberg
July 1995, Acta paediatrica (Oslo, Norway : 1992),
V Nordin, and A Lekman, and M Johansson, and P Fredman, and C Gillberg
March 2008, Current neurology and neuroscience reports,
V Nordin, and A Lekman, and M Johansson, and P Fredman, and C Gillberg
February 2011, Pediatric neurology,
V Nordin, and A Lekman, and M Johansson, and P Fredman, and C Gillberg
September 2008, Current treatment options in neurology,
V Nordin, and A Lekman, and M Johansson, and P Fredman, and C Gillberg
June 2019, Autism research : official journal of the International Society for Autism Research,
V Nordin, and A Lekman, and M Johansson, and P Fredman, and C Gillberg
April 2007, Journal of autism and developmental disorders,
V Nordin, and A Lekman, and M Johansson, and P Fredman, and C Gillberg
October 2012, Indian journal of pediatrics,
V Nordin, and A Lekman, and M Johansson, and P Fredman, and C Gillberg
February 1969, Klinische Wochenschrift,
Copied contents to your clipboard!